Carregant...
Anticoagulation Strategies in Patients With Cancer
Patients with active cancer are at an increased risk of arterial and venous thromboembolism (VTE) and bleeding events. Historically, in patients with cancer, low molecular weight heparins have been preferred for treatment of VTE, whereas warfarin has been the standard anticoagulant for stroke preven...
Guardat en:
| Publicat a: | J Am Coll Cardiol |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7957366/ https://ncbi.nlm.nih.gov/pubmed/30898209 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2019.01.017 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|